DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy

Journal Article · · Journal of Clinical Investigation
DOI: https://doi.org/10.1172/JCI171554 · OSTI ID:1991123
ORCiD logo; ORCiD logo; ORCiD logo; ORCiD logo; ; ; ; ; ORCiD logo; ORCiD logo; ; ORCiD logo; ; ORCiD logo; ; ORCiD logo; ORCiD logo; ORCiD logo; ORCiD logo; ORCiD logo more »; ORCiD logo; ORCiD logo; ORCiD logo; ORCiD logo; ; « less

Not Available

Research Organization:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Organization:
National Institutes of Health (NIH); USDOE; USDOE National Nuclear Security Administration (NNSA)
Grant/Contract Number:
89233218CNA000001
OSTI ID:
1991123
Report Number(s):
LA-UR--23-24125; e171554
Journal Information:
Journal of Clinical Investigation, Journal Name: Journal of Clinical Investigation Journal Issue: 17 Vol. 133; ISSN 1558-8238
Publisher:
American Society for Clinical InvestigationCopyright Statement
Country of Publication:
United States
Language:
English

References (87)

Intermittent HIV-1 Viremia (Blips) and Drug Resistance in Patients Receiving HAART journal February 2005
HIV-1 replication is controlled at the level of T cell activation and proviral integration. journal May 1990
Measuring the Frequency of Latent HIV-1 in Resting CD4+ T Cells Using a Limiting Dilution Coculture Assay book January 2016
Immunologic Control of HIV-1: What Have We Learned and Can We Induce It? journal March 2021
HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots journal August 2002
The T Cell Activation Factor NF-ATc Positively Regulates HIV-1 Replication and Gene Expression in T Cells journal March 1997
Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure journal October 2013
HIV-1 Integration Landscape during Latent and Active Infection journal January 2015
Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses journal January 2022
Extensive characterization of HIV-1 reservoirs reveals links to plasma viremia before and during analytical treatment interruption journal April 2022
Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy journal January 2023
Antiretroviral therapy reveals triphasic decay of intact SIV genomes and persistence of ancestral variants journal March 2023
Single-cell multiomics reveals persistence of HIV-1 in expanded cytotoxic T cell clones journal June 2022
New insights into transcription elongation control of HIV-1 latency and rebound journal January 2023
An inducible transcription factor activates expression of human immunodeficiency virus in T cells journal April 1987
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection journal May 1997
Decay characteristics of HIV-1-infected compartments during combination therapy journal May 1997
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy journal May 1999
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy journal July 2012
Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys journal July 2014
Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys journal November 2016
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation journal June 2009
Defective proviruses rapidly accumulate during acute HIV-1 infection journal August 2016
In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency journal December 1995
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells journal May 2003
A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation journal November 2018
Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion journal February 2019
The role of CD32 during HIV-1 infection journal September 2018
Combination therapy with anti-HIV-1 antibodies maintains viral suppression journal September 2018
A quantitative approach for measuring the reservoir of latent HIV-1 proviruses journal January 2019
Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo journal January 2020
Distinct viral reservoirs in individuals with spontaneous control of HIV-1 journal August 2020
Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection journal June 2018
Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial journal October 2022
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less journal September 1997
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy journal September 1997
Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption journal February 2015
Clonally expanded CD4 + T cells can produce infectious HIV-1 in vivo journal February 2016
Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA journal November 2016
Strain-induced accelerated asymmetric spatial degradation of polymeric vascular scaffolds journal February 2018
Defective HIV-1 proviruses produce viral proteins journal February 2020
Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNA journal July 2020
Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1 journal November 2020
Complex decay dynamics of HIV virions, intact and defective proviruses, and 2LTR circles following initiation of antiretroviral therapy journal February 2022
Identification of T cell-signaling pathways that stimulate latent HIV in primary cells journal October 2003
Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. journal August 1989
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy journal November 1997
Early establishment of a pool of latently infected, resting CD4+ T cells during primary HIV-1 infection journal July 1998
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression journal December 1999
Proliferation of latently infected CD4 + T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics journal March 2017
Relationship between latent and rebound viruses in a clinical trial of anti–HIV-1 antibody 3BNC117 journal August 2018
Antigen-responsive CD4+ T cell clones contribute to the HIV-1 latent reservoir journal April 2020
Integration features of intact latent HIV-1 in CD4+ T cell clones contribute to viral persistence journal October 2021
Establishment of a CCR5-Expressing T-Lymphoblastoid Cell Line Highly Susceptible to R5 HIV Type 1 journal July 2000
Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy journal August 2020
Varied Patterns of Decay of Intact Human Immunodeficiency Virus Type 1 Proviruses Over 2 Decades of Antiretroviral Therapy journal February 2023
Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV Therapy journal February 2015
Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies journal April 2015
Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy journal June 2017
Designing and Interpreting Limiting Dilution Assays: General Principles and Applications to the Latent Reservoir for Human Immunodeficiency Virus-1 journal January 2015
Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro journal October 1997
Specific HIV integration sites are linked to clonal expansion and persistence of infected cells journal June 2014
Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection journal July 2014
Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia journal November 1997
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy journal November 1997
Different human resting memory CD4 + T cell subsets show similar low inducibility of latent HIV-1 proviruses journal January 2020
Signatures of immune selection in intact and defective proviruses distinguish HIV-1 elite controllers journal December 2021
Residual Human Immunodeficiency Virus Type 1 Viremia in Some Patients on Antiretroviral Therapy Is Dominated by a Small Number of Invariant Clones Rarely Found in Circulating CD4+ T Cells journal June 2006
An Increasing Proportion of Monotypic HIV-1 DNA Sequences during Antiretroviral Treatment Suggests Proliferation of HIV-Infected Cells journal November 2012
Cyclin T1 and CDK9 T-Loop Phosphorylation Are Downregulated during Establishment of HIV-1 Latency in Primary Resting Memory CD4+ T Cells journal November 2012
Resting CD4+ T Cells from Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Individuals Carry Integrated HIV-1 Genomes within Actively Transcribed Host Genes journal June 2004
Evidence that Low-Level Viremias during Effective Highly Active Antiretroviral Therapy Result from Two Processes: Expression of Archival Virus and Replication of Virus journal July 2005
The Molecular Basis for Human Immunodeficiency Virus Latency journal September 2017
HIV-1 latent reservoir size and diversity are stable following brief treatment interruption journal June 2018
Longitudinal study reveals HIV-1–infected CD4+ T cell dynamics during long-term antiretroviral therapy journal June 2020
HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus journal October 2020
Antigen-driven clonal selection shapes the persistence of HIV-1–infected CD4+ T cells in vivo journal February 2021
Differential decay of intact and defective proviral DNA in HIV-1–infected individuals on suppressive antiretroviral therapy journal February 2020
Regulation of nuclear factor of activated T cells by phosphotyrosyl-specific phosphatase activity: a positive effect on HIV-1 long terminal repeat–driven transcription and a possible implication of SHP-1 journal April 2001
ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia journal January 2007
Absence of HIV-1 Evolution in the Gut-Associated Lymphoid Tissue from Patients on Combination Antiviral Therapy Initiated during Primary Infection journal February 2012
Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies journal February 2013
Rapid Quantification of the Latent Reservoir for HIV-1 Using a Viral Outgrowth Assay journal May 2013
Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir journal March 2017
Integration in oncogenes plays only a minor role in determining the in vivo distribution of HIV integration sites before or during suppressive antiretroviral therapy journal April 2021
Biogenesis of P-TEFb in CD4+ T cells to reverse HIV latency is mediated by protein kinase C (PKC)-independent signaling pathways journal September 2021
HIV infected CD4+ T cell clones are more stable than uninfected clones during long-term antiretroviral therapy journal August 2022